Antiplatelet treatment of cardiovascular disease: A translational research perspective

Keyphrases

• Cardiovascular Disease 100%
• Translational Research 100%
• Ischemic Events 100%
• Event Occurrence 100%
• Antiplatelet Treatment 100%
• Dual Antiplatelet Therapy 66%
• Patients with Cardiovascular Diseases 66%
• Risk Factors 33%
• Pharmacological Therapy 33%
• Platelets 33%
• Aspirin 33%
• Clinical Trials 33%
• Clinical High Risk 33%
• Modifiable Risk Factors 33%
• Treatment Strategy 33%
• Putative Drug Targets 33%
• Adenosine Diphosphate 33%
• Thrombosis 33%
• Thrombus 33%
• Standard of Care 33%
• Platelet Reactivity 33%
• Clopidogrel 33%
• Response Variability 33%
• P2Y12 Inhibitors 33%
• Recurrent Ischemic Events 33%
• P2Y12 Receptor 33%
• Acute Coronary Artery Syndrome 33%
• High On-treatment Platelet Reactivity 33%

Medicine and Dentistry

• Cardiovascular Disease 100%
• Translational Research 100%
• Antiplatelet 100%
• Platelet Reactivity 50%
• Clinical Trial 25%
• Coronary Artery 25%
• Platelet 25%
• Acetylsalicylic Acid 25%
• Thrombus 25%
• Thrombosis 25%
• Adenosine Diphosphate 25%
• Clopidogrel 25%
• Purinergic P2Y12 Receptor 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Cardiovascular Disease 100%
• Antiplatelet 100%
• Clinical Trial 25%
• Acetylsalicylic Acid 25%
• Syndrome 25%
• Adenosine Diphosphate 25%
• Thrombosis 25%
• Clopidogrel 25%
• Thrombus 25%
• Purinergic P2Y12 Receptor 25%